Chronic myeloid leukemia in the tyrosine kinase inhibitor era: What is the "best" therapy?

Meetu Agrawal, Ravin J. Garg, Hagop Kantarjian, Jorge Cortes

Research output: Contribution to journalReview articlepeer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Chronic myeloid leukemia in the tyrosine kinase inhibitor era: What is the "best" therapy?'. Together they form a unique fingerprint.

Medicine & Life Sciences